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Abstract Synapses and nuclei are connected by bidirectional communication mechanisms that
enable information transfer encoded by macromolecules. Here, we identified RNF10 as a novel
synaptonuclear protein messenger. RNF10 is activated by calcium signals at the postsynaptic
compartment and elicits discrete changes at the transcriptional level. RNF10 is enriched at the
excitatory synapse where it associates with the GluN2A subunit of NMDA receptors (NMDARs).
Activation of synaptic GluN2A-containing NMDARs and induction of long term potentiation (LTP)
lead to the translocation of RNF10 from dendritic segments and dendritic spines to the nucleus. In
particular, we provide evidence for importin-dependent long-distance transport from synapto-
dendritic compartments to the nucleus. Notably, RNF10 silencing prevents the maintenance of LTP
as well as LTP-dependent structural modifications of dendritic spines.
DOI: 10.7554/eLife.12430.001
Introduction
Understanding how local synaptic events are translated into changes in gene expression is a crucial
question in neuroscience. Synapses and nuclei are efficiently connected by bidirectional communica-
tion routes that enable transfer of information (Fainzilber et al., 2011; Panayotis et al., 2015) and
regulate the transcription of genes associated with long-term structural changes of neuronal excit-
ability (Karpova et al., 2012). NMDAR activation plays a key role in this regard (Hardingham and
Bading, 2010). NMDARs are heteromeric ionotropic channels that are essential for excitatory neuro-
transmission (Paoletti et al., 2013; Sanz-Clemente et al., 2013). NMDARs differ in their subunit
composition and, in the forebrain, they can be either di- or tri-heteromeric tetramers consisting of
two GluN1 and either one or two GluN2A or GluN2B subunits (Paoletti et al., 2013). GluN2A-con-
taining NMDARs are mainly localized at the postsynaptic membrane, at the core of the postsynaptic
density (PSD), while the GluN2B-containing NMDARs are also prominently present at extrasynaptic
sites (Hardingham and Bading, 2010). In addition, numerous reports have indicated that GluN2A-
and GluN2B-containing NMDARs may play different roles in the modulation of synaptic plasticity
and in central nervous system (CNS) disorders (Paoletti et al., 2013). These differences in receptor
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function are probably linked to the cytoplasmic C-tail of the two subunits, which are fairly different
and contain specific motifs that bind to PSD-associated scaffolding proteins and to proteins involved
in the downstream signal transduction of receptor activation (Sanz-Clemente et al., 2013;
Sun et al., 2016).
It is generally accepted that rises in synaptic, somatic and nuclear Ca2+ rapidly regulate gene
expression by Ca2+-sensing mechanisms (Bading, 2013). Recent work showed that following a fast
genomic response to sustained rises in Ca2+, a considerably slower process that depends on the
nuclear import of proteins released from synapses couples local synaptic events to more specific
gene expression programs (Jordan and Kreutz, 2009; Ch’ng and Martin, 2011; Karpova et al.,
2012). The classical active nuclear import pathway involves the binding of importin a isoforms to
nuclear localization signal (NLS) bearing cargo proteins. Interestingly, neuronal importins are present
at synapses in association with NMDARs and the PSD (Dieterich et al., 2008; Jeffrey et al., 2009)
and they are able to translocate to the nucleus in response to NMDAR activation (Thompson et al.,
2004; Dieterich et al., 2008). Proteomic studies have identified many proteins in purified synapto-
somes that contain a NLS domain, and in the past 10 years, an impressive number of potential syn-
aptonuclear messenger proteins have been characterized (Ch’ng et al., 2012; Karpova et al., 2013;
Kaushik et al., 2014). Many of these proteins contain a bona fide NLS and, in some cases, their
binding with importin a was shown to be essential for long-distance transport as importin a can
serve as an adaptor for nuclear trafficking of cargo in association with a dynein motor
(Karpova et al., 2012; Ch’ng et al., 2012).
In recent studies, it was shown that Jacob, a Caldendrin-binding protein abundantly expressed in
limbic brain and cortex (Dieterich et al., 2008), encodes and transduces the synaptic and extrasy-
naptic origin of GluN2B-containing NMDAR signals to the nucleus and elicits the divergent transcrip-
tional responses after activation of these receptors (Dieterich et al., 2008; Karpova et al., 2013).
These findings point to the fascinating possibility that specific NMDAR signals are encoded at synap-
tic sites and decoded in the nucleus by long-distance trafficking of protein messengers.
eLife digest Brain activity depends on the communication between neurons. This process takes
place at the junctions between neurons, which are known as synapses, and typically involves one of
the cells releasing a chemical messenger that binds to receptors on the other cell. The binding
triggers a cascade of events inside the recipient cell, including the production of new receptors and
their insertion into the cell membrane. These changes strengthen the synapse and are thought to be
one of the ways in which the brain establishes and maintains memories.
However, in order to induce these changes at the synapse, neurons must be able to activate the
genes that encode their component parts. These genes are present inside the cell nucleus, which is
located some distance away from the synapse. Studies have shown that signals can be sent from the
nucleus to the synapse and vice versa, enabling the two parts of the cell to exchange information.
Synapses that communicate using a chemical called glutamate have been particularly well studied;
but it still remains unclear how the activation of receptors at these “glutamatergic synapses” is
linked to activation of genes inside the nucleus at the molecular level.
Dinamarca, Guzzetti et al. have now discovered that this process at glutamatergic synapses
involves the movement of a protein messenger to the nucleus. Specifically, activation at synapses of
a particularly common subtype of receptor, called NMDA, causes a protein called Ring Finger
protein 10 (or RNF10 for short) to move from the synapse to the nucleus. To leave the synapse,
RNF10 first has to bind to proteins called importins, which transport RNF10 into the nucleus. Once
inside the nucleus, RNF10 binds to another protein that interacts with the DNA to start the
production of new synaptic proteins.
Further work is required to identify the molecular mechanisms that trigger RNF10 to leave the
synapse. In addition, future studies should evaluate the levels and activity of RNF10 in brain
disorders in which synapses are known to function abnormally.
DOI: 10.7554/eLife.12430.002
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Here, we identified Ring Finger protein 10 (RNF10; Seki et al., 2000) as a novel synaptonuclear
protein messenger, localized at the PSD and specifically associated to the cytoplasmic tail of GluN2A
but not GluN2B subunit of NMDARs. After stimulation of synaptic GluN2A-containing NMDARs,
RNF10 binds to importin a1 for nuclear long-distance transport. Notably, we show that long-term
potentiation (LTP) induces nuclear translocation of RNF10, its interaction with the transcription factor
Meox2 and the modulation of gene expression. Most interestingly, RNF10-regulated gene expres-
sion appears to feed back to synaptic function.
Results
RNF10 is a neuronal synaptic protein
In order to identify new binding partners for GluN2A, we performed a yeast two-hybrid screening
using the C-terminal domain (aa 839–1461, without the aa 1462–1464 PDZ-binding sequence) as
bait. We obtained a number of positive clones including RNF10 (Seki et al., 2000;
Hoshikawa et al., 2008). In Schwann cells, RNF10 has a function in the transcriptional regulation of
myelin formation (Hoshikawa et al., 2008). However, very little is known about the neuronal function
of this protein (Seki et al., 2000; Lin et al., 2005; Hoshikawa et al., 2008; Malik et al., 2013).
Using specific glial (GFAP) and neuronal (MAP2) markers, we confirmed that RNF10 is expressed in
both glia (Figure 1A) and neurons (Figure 1B). Interestingly, in neurons RNF10 displayed a nuclear
and somatodendritic distribution (Figure 1B). Moreover, transfected GFP-RNF10 displayed a promi-
nent co-localization with PSD-95 and GluN2A at the dendritic spines of hippocampal neurons
(Figure 1C). Similarly, analysis of endogenous RNF10 in DIV14 primary hippocampal neurons showed
clustered RNF10 immunolabeling along dendrites and most puncta co-localized with GluN2A
(Figure 1D, left panels) and PSD-95 (Figure 1D, right panels). PSDs from the rat hippocampus were
purified to confirm the subcellular distribution of RNF10 by a biochemical approach. Subcellular frac-
tionation demonstrated that RNF10 is associated with synaptic fractions and that it is prominently
present in PSD fractions (Figure 1E). Finally, immunofluorescence analysis of the CA1 region of the
adult rat hippocampus revealed the presence of an intense signal for RNF10 in the soma and nuclei
together with a punctate staining along MAP2-positive dendrites (Figure 1F).
Interestingly, GluN2A silencing in primary hippocampal neurons (Figure 1G) induced a significant
decrease in RNF10 synaptic levels, as indicated by the reduction of RNF10 co-localization with PSD-
95 (Figure 1H). Notably, the remaining dendritic RNF10 in shGluN2A neurons co-localized with the
surface GluN2A pool unaffected by the knock down (Figure 1I). However, no modification of RNF10
nuclear level was observed following GluN2A silencing (data not shown; n=30; p=0.5491; shGluN2A
vs scramble; unpaired Student’s t-test).
RNF10 interacts with the GluN2A subunit of NMDARs
Different experimental approaches were used to substantiate the yeast two-hybrid data and to con-
firm the interaction between RNF10 and GluN2A. Co-immunoprecipitation (co-i.p.) studies per-
formed from hippocampal P2 crude membrane fractions indicated a specific interaction of RNF10
with GluN2A but not with GluN2B subunit of the NMDARs (Figure 2A). No signal for GluN2A or
GluN2B was obtained by using anti-synaptophysin as an irrelevant antibody or in the absence of anti-
body in the co-i.p. assay (Figure 2A). To further validate these findings we performed similar experi-
ments with the GluN2B-associated synapse-to-nucleus messenger Jacob (Dieterich et al., 2008;
Karpova et al., 2013). Indeed, the affinity-purified pan-Jacob antibody preferentially co-i.p. GluN2B
from rat brain homogenate. Only a very faint band of GluN2A was detected in the complex with
Jacob (Figure 2B), which might potentially represent synaptic tri-heteromeric GluN1/GluN2A/
GluN2B NMDARs.
In addition, cell lysates from COS-7 cells transfected with HA-GluN1 and GFP-GluN2A or GFP-
GluN2B constructs were immunoprecipitated with anti-RNF10 and immunoblotted for GFP. The
results confirmed that GluN2A interacts with RNF10, whereas GluN2B failed to associate with
RNF10 (Figure 2C). To corroborate these results, we transfected HA-GluN1 and either GFP-GluN2A
or GFP-GluN2B constructs in heterologous cells (COS-7) endogenously expressing RNF10. Immuno-
fluorescence studies revealed the presence of RNF10 aggregates with a high co-localization degree
with GluN2A but not with GluN2B (Figure 2D; 73.8% ± 2.9% GluN2A/RNF10 vs 31.3.% ± 1.7%
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Figure 1. RNF10 subcellular distribution in neurons. (A,B) Mixed primary hippocampal cultures (DIV14) immunolabeled with antibodies for RNF10 (red),
glial marker GFAP (A; green) or the neuronal marker MAP2 (B; green), and Dapi (blue) to stain the nucleus; scale bar: 20 mm. (C) Dendrite of
hippocampal neuron transfected with GFP-RNF10 (DIV7) and immunolabeled at DIV14 for GFP (green), GluN2A (red) and PSD-95 (blue); scale bar:
3 mm. (D) High-magnification confocal images of neuronal dendrites (DIV14) immunolabeled for endogenous RNF10 (green) and GluN2A (red; left
panels) or PSD-95 (red; right panels); scale bar: 4 mm. (E) RNF10 and markers of the presynaptic (synaptophysin) and postsynaptic compartment (PSD-
95, GluN2A) were analyzed by WB in various subcellular compartments (H: Homogenate fraction; S1: supernatant 1; P1: nuclear fraction; S2: cytosolic
fraction 2; P2: crude membrane fraction 2; Syn: synaptosomal fraction; PSD1: Triton Insoluble postsynaptic fraction; PSD2: postsynaptic density fraction).
(F) Representative confocal images of adult rat hippocampal CA1 pyramidal layer sections showing immunohistochemical labeling for RNF10 (red),
MAP2 (green), and Dapi (blue); scale bar: 40 mm. (G) Confocal images of dendrites from hippocampal neurons (DIV14) transfected at DIV7 with
shGluN2A or scramble vector and immunolabeled for GluN2A; scale bar: 4 mm. The histogram shows the quantification of GluN2A integrated density in
dendrites (n=7, **p=0.0069 scramble vs shGluN2A; unpaired Student’s t-test). (H) GluN2A silencing induces a reduction of RNF10 enrichment at the
glutamatergic synapse. Confocal images of primary hippocampal neurons transfected with pGFP-V-RS-scramble (left panels) or with pGFP-V-RS-
shGluN2A (right panels) plasmids and immunolabeled (DIV14) for RNF10 (green) and PSD-95 (red); scale bar: 4 mm. The histogram shows the
quantification of RNF10 co-localization with PSD-95-positive puncta (n=30, ***p<0.001; unpaired Student’s t-test). (I) Confocal images of dendrites from
hippocampal neurons (DIV14) transfected at DIV7 with shGluN2A or scramble vector and immunolabeled for surface GluN2A (blue) and RNF10 (red);
scale bar: 4 mm.
DOI: 10.7554/eLife.12430.003
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Figure 2. RNF10 interaction with GluN2A-containing NMDARs. (A) Co-immunoprecipitation (co-i.p.) assay performed in P2 crude membrane fractions
by using antibodies against PSD-95, RNF10, synaptophysin (Syn) and GluN2A. WB analysis shows the levels of GluN2A (left panel) and GluN2B (right
panel) in the co-immunoprecipitated material. No ab lane: control lane in absence of antibodies during the co-i.p. assay. (B) Jacob is a part of the
GluN2B receptor complex. Affinity purified pan-Jacob antibodies co-immunoprecipitate GluN2B. (C) Co-i.p. assay performed by using an anti-RNF10
antibody from COS-7 cell extracts transfected with HA-GluN1 and GFP-GluN2A or GFP-GluN2B. WB analysis was performed by using anti-GFP and
anti-RNF10 antibodies. No ab lane: control lane in absence of antibodies during the co-i.p. assay. (D) COS-7 cells expressing RNF10 were transfected
with HA-GluN1 and GFP-GluN2A or GFP-GluN2B constructs and immunolabeled for GFP (green), GluN1 (blue), Dapi (cyan) and endogenous RNF10
(red); scale bar: 10 mm. (E) In situ detection of proximity between RNF10 and GluN2A (red) along MAP2 (green; left panels) or GFP-positive (green; right
panels) dendrites. In control experiments (-), primary hippocampal neurons were labeled with only RNF10 primary antibody and thus only unspecific
PLA signals are generated; scale bars: 5 mm (MAP2) and 3 mm (GFP). (F, G) COS-7 cells expressing RNF10 were transfected with GFP-GluN2A (right
panels) or GFP-GluN2B (left panels) constructs and immunolabeled for GFP (green), Dapi (cyan) and endogenous RNF10 (red); scale bar: 10 mm. The
histogram shows the quantification of RNF10 integrated density (i.d.) expressed as cytoplasm/nucleus ratio (n=10; ***p<0.001; one-way ANOVA,
followed by Bonferroni post-hoc test).
DOI: 10.7554/eLife.12430.004
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GluN2B/RNF10; p<0.001, n=15; unpaired Student’s t-test). Finally, RNF10 clustering with GluN2A at
synapses was confirmed by proximity ligation assay (PLA). As shown in Figure 2E, a large number of
PLA signals were detected when the two antibodies RNF10 and GluN2A were used indicating these
two proteins are in close proximity (<40 nm) to each other. As expected, PLA signals were distrib-
uted along MAP2-positive dendrites (Figure 2E, left panels) and at the top of GFP-positive dendritic
spines (Figure 2E, right panels). For control experiments, only RNF10 primary antibody was used
and no PLA signal was generated (Figure 2E).
Notably, transfection of COS-7 cells with GluN2A but not GluN2B induces a highly significant
redistribution of endogenous RNF10 from the nucleus to the cytoplasm, thus suggesting that
GluN2A traps RNF10 outside the nucleus (Figure 2F–G). Overall, these results demonstrate that
RNF10 is a component of the excitatory PSD and that it is specifically associated with GluN2A-con-
taining NMDARs.
The RNF10 N-terminus binds to the juxta-membrane region of GluN2A
We next mapped the binding interface of the interaction between RNF10 and GluN2A using trunca-
tion constructs in pull-down and co-i.p. experiments. The pull-down assay performed from adult rat
brain tissue using glutathione S-transferase (GST)-GluN2A C-terminal domain fusion proteins
(Figure 3A) revealed that RNF10 interacts with the GluN2A cytoplasmic tail (CT; aa 839–1464) but
failed to bind the distal part of the GluN2A C-terminus (aa 1049–1464) (Figure 3B, upper panel). In
addition, GluN2A(839–991) failed to interact with RNF10 (Figure 3B, lower panel), thus indicating
GluN2A(991–1049) is needed for the formation of the GluN2A/RNF10 complex.
To strengthen these results, GFP-GluN2A (1–1049) truncation mutant (bearing a stop codon at aa
1049) was transfected in COS-7 cells to evaluate its capability to interact with endogenous RNF10
(Figure 3C,D). Immunofluorescence assay revealed a high GFP-GluN2A(1–1049)/RNF10 clustering
leading also to RNF10 redistribution from the nucleus to the cytoplasm (Figure 3C; cytoplasm/
nucleus ratio 0.98 ± 0.04 vs 0.26 ± 0.02 GFP-GluN2A(1–1049) vs untransfected, p<0.001, n=10;
unpaired Student’s t-test), similarly to what has been described above for GFP-GluN2A construct
(see Figure 2). Accordingly, RNF10 co-immunoprecipitated with both GFP-GluN2A and GFP-
GluN2A (1–1049) from COS-7 lysates (Figure 3D), confirming that RNF10 interacts with the GluN2A
juxta-membrane aa 839–1049 region. Interestingly, GluN2A(991–1029) domain previously shown to
be responsible for a calcium-dependent binding of the NMDAR subunit with Calmodulin (CaM;
Bajaj et al., 2014). Based on this consideration, we first evaluated whether calcium (Ca2+) could
modulate GluN2A/RNF10 interaction. Using a pull-down assay we found that the presence of free
Ca2+ (2 mM) in the buffer significantly reduced GluN2A binding to GST-RNF10 FL (Figure 3E; -
37.8% ± 6.2%; p<0.01). Similarly presence of free Ca2+ (2 mM) in the buffer significantly reduced
RNF10 binding to GST-GluN2A(839–1464) (Figure 3F; -65.4 ± 8.8%; p<0.05). As previously reported
(Bajaj et al., 2014), Ca2+ induced also the binding of CaM to the GluN2A fusion protein (Figure 3F).
In addition, co-incubation with exogenous CaM completely prevented the interaction between
RNF10 and GluN2A in the pull-down assay (Figure 3G) only in the presence of Ca2+ in the buffer
(Bajaj et al., 2014). Similarly, a co-i.p. assay from COS-7 cells transfected with GFP, GFP-GluN2A or
GFP-GluN2B confirmed the capability of Ca2+/CaM to disrupt RNF10/GluN2A complex (Figure 3H).
The RNF10 protein contains a binding sequence for the transcription factor Mesenchyme Homeo-
box 2 (Meox2; Meox2 Binding Domain, MBD, aa 101–185; Lin et al., 2005), a Ringer Finger Domain
(RFD, aa 225–270) and two putative nuclear localization sequences (NLS1, aa 591–599 and NLS2, aa
784–791). Several Myc-RNF10 mutants were prepared and co-transfected with GluN2A in COS-7
cells in order to identify the RNF10 domain responsible for the interaction with the NMDAR subunit.
The RNF10(221–802) construct failed to interact with GluN2A as demonstrated by both co-i.p.
(Figure 3I) and co-localization (Figure 3K,L) assays when compared to RNF10 full length (FL). Con-
versely, all RNF10 truncation mutants bearing the RNF10(1–221) domain co-immunoprecipitated
with GFP-GluN2A (Figure 3J). Finally, pull-down assay performed from adult rat brain tissue using
GST-RNF10 fusion proteins confirmed that the RNF10 N-terminal region 1–221 is crucial for the
binding to GluN2A (Figure 3M).
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Figure 3. RNF10 N-terminal domain interacts with the juxtamembrane region of GluN2A C-tail. (A) Scheme
showing GST-GluN2A fusion proteins used in the pull-down assay. (B) GST and GST-GluN2A fusion proteins were
incubated in a pull-down assay with rat hippocampal extracts. WB analysis was performed with RNF10 antibody.
(C) Confocal images of COS-7 cells transfected with GFP-GluN2A (1–1049) and immunolabeled for GFP (green),
Dapi (cyan) and RNF10 (red); scale bar: 10 mm. (D) Co-i.p. assay performed from lysates of COS-7 cells transfected
with GFP-GluN2A or GFP-GluN2A(1–1049). WB analysis was performed by using a GFP antibody (JL-8). (E) GST
and GST-RNF10 full-length (FL) fusion proteins were incubated in a pull-down assay with rat hippocampal extracts
in presence or absence of calcium (2 mM). WB analysis was performed with GluN2A antibody. (F) GST and GST-
GluN2A(839–1464) fusion proteins were incubated in a pull-down assay with rat hippocampal extracts in presence
or absence of calcium (2 mM). WB analysis was performed with RNF10 and CaM antibodies. (G) GST and GST-
GluN2A(839–1049) fusion proteins were incubated in a pull-down assay with rat hippocampal extracts with CaM
(0.1 mM) in the presence or absence of calcium (2 mM). WB analysis was performed with RNF10 and CaM
antibodies. (H) Co-i.p. assay performed from lysates of COS-7 cells transfected with GFP, GFP-GluN2A or GFP-
Figure 3 continued on next page
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RNF10 silencing induces molecular and morphological modifications of
the glutamatergic synapse
RNF10 is a member of the Ring Finger Protein family, which has been generally implicated in devel-
opment, transcriptional regulation, signal transduction, DNA repair and oncogenesis (Saurin et al.,
1996). However, the neuronal function of RNF10 is still unknown (Lin et al., 2005; Malik et al.,
2013). To understand the role of RNF10 in neurons, we silenced RNF10 expression by using a short
hairpin (sh) RNF10 knock-down or a scramble sequence (as control) in primary hippocampal cultures.
We tested three different sequences of RNF10 shRNA (shRNF10; see Materials and methods);
shRNF10 that led to the highest level of RNF10 downregulation (>90%; TRCN0000041128) was
selected and used in all experiments. Confocal imaging of hippocampal neurons transfected with
shRNF10 or scramble plasmids demonstrated a significant effect of RNF10 knock-down on dendritic
spine morphology (Figure 4A–E). In particular, RNF10 silencing produced a significant reduction in
dendritic spine density (Figure 4B) without any effect on dendritic spine length (Figure 4C) or den-
dritic spine head width (Figure 4D). For a more detailed morphological analysis, dendritic spines
were categorized according to their shape (mushroom, thin and stubby) using a validated classifica-
tion method (Bourne and Harris, 2008). However, no effect of shRNF10 in the proportion of den-
dritic spine subtypes was observed (Figure 4E). Notably, the effect of RNF10 silencing on dendritic
spine density was fully rescued by co-expressing a wild-type human variant of RNF10 resistant to
shRNA (see Materials and methods; flag-RNF10; Figure 4A–E). Interestingly, overexpression of
RNF10 per se had no effect on dendritic spine morphology (data not shown). We then verified
whether the loss of spines following RNF10 protein knock-down was correlated with an altered
expression of the main components of the excitatory synapse. To this end, we infected primary hip-
pocampal neurons (Figure 4F, left panels) and organotypic hippocampal slices (Figure 4F, right pan-
els) with pLKO-shRNF10 lentivirus or scramble sequence as a control. As expected, RNF10 silencing
produced a significant reduction of RNF10 protein level compared to dissociated neurons and slices
treated with scramble construct (Figure 4F). Most importantly, RNF10 silencing resulted in a signifi-
cant decrease of GluN2A, PSD-95 and the GluA1 subunit of the AMPA receptor (AMPAR) protein
levels in the total cell homogenate of pLKO-shRNF10-infected dissociated neurons and organotypic
slices (Figure 4F).
To learn more about the effect of RNF10 knock-down on gene expression, we performed a micro-
array analysis from organotypic hippocampal slices virally infected with pLKO-shRNF10 lentivirus in
order to identify RNF10 target genes. Interestingly, heat map of differentially expressed genes
(Figure 5A), gene ontology analysis (Figure 5B) and real-time PCR validation (Figure 4G) showed
that RNF10 silencing modulated the expression of several genes involved in excitatory synaptic
transmission and dendritic spine morphology (Vogt et al., 2007; Michaluk et al., 2011;
Ramakers et al., 2012). Furthermore, we confirmed by WB analysis the effect of viral infection with
pLKO-shRNF10 on protein levels of some of the RNF10 target genes, such as Ophn1, ArhGap4 and
ArhGef6 (Figure 4H).
Figure 3 continued
GluN2B in the presence or absence of calcium (2 mM)/CaM (0.1 mM). WB analysis was performed by using RNF10
and CaM antibodies. (I) Co-i.p assay performed by using a GFP antibody from lysates of COS-7 cells transfected
with RNF10 FL, RNF10(221–802) and GFP-GluN2A. WB analysis was performed by using a Myc antibody. No ab
lanes: control lanes in absence of antibodies during the co-i.p. assay. (J) Co-i.p assay performed by using a Myc
antibody from lysates of COS-7 cells transfected with RNF10 truncation mutants and GFP-GluN2A. WB analysis
was performed by using a GFP antibody (JL-8). (K,L) COS-7 cells expressing RNF10 were transfected with GFP-
GluN2A and Myc-RNF10 FL or Myc-RNF10 (221–802) constructs and immunolabeled for GFP (green), Myc (red)
and Dapi (blue) (G); scale bar: 10 mm. The histogram (H) shows the quantification of Myc/EGFP co-localization
index [n=10; ***p<0.001 RNF10 FL vs RNF10(221–802); unpaired Student’s t-test]. (M) GST and GST-RNF10 fusion
proteins were incubated in a pull-down assay with rat hippocampal extracts. WB analysis was performed with
GluN2A antibody.
DOI: 10.7554/eLife.12430.005
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Neuronal activity regulates RNF10 synaptonuclear localization
The synaptic and nuclear localization in neurons, the presence of two different NLS motifs and its
interaction with GluN2A and Meox2 (Lin et al., 2005) suggest that RNF10 could be a novel synapto-
nuclear protein messenger. To validate this hypothesis, we assessed whether the modulation of neu-
ronal activity affects the subcellular localization of RNF10 and its association with the interacting
proteins. We first enhanced synaptic excitatory activity with the GABA-A receptor antagonist Bicu-
culline (50 mM) in the presence of the K+ channel blocker 4-AP (2.5 mM; Hardingham et al., 2002)
(’Bic’ treatment). Enhanced excitatory activity significantly decreased RNF10 immunoreactivity along
Figure 4. RNF10 silencing induces molecular and morphological modifications of the glutamatergic synapse. (A) Confocal images of primary
hippocampal neurons (DIV14) transfected at DIV7 with pGIPZ-scramble, shRNF10 and shRNF10 plus flagRNF10 and immunolabeled for GFP (green);
scale bar: 5 mm. (B-E) Histograms showing the quantification of dendritic spine density (B) (n=6–10; *p<0.05, scramble vs shRNF10; ***p<0.001,
shRNF10 vs shRNF10 + flagRNF10; one-way ANOVA, followed by Tukey post-hoc test), dendritic spine length (C), dendritic spine head width (D) and
dendritic spine type (E). (F) WB analysis from homogenates of primary hippocampal neurons (DIV14) and organotypic hippocampal slices (DIV14)
lentivirally infected with pGIPZ-scramble sequence (scramble) as control or with pLKO-shRNF10 (shRNF10). The histogram shows the quantification of
the expression levels of GluN2A, GluA1, PSD-95 and GluN2B in shRNF10-infected neurons and slices, normalized on tubulin and expressed as % of
scramble (n=6; *p<0.05; **p<0.01; unpaired Student’s t-test). (G) mRNA expression levels of genes associated with synaptic transmission or dendritic
spine morphology by real-time PCR from DIV14 organotypic hippocampal slices lentivirally infected (DIV4) with pGIPZ-scramble sequence (scramble) as
control or with pLKO-shRNF10 (shRNF10) (n=4, ***p<0.001; **p<0.01; *p<0.05; unpaired Student’s t-test). (H) WB for ArhGef6, ArhGap4, Ophn1 and
tubulin from cell lysates of organotypic hippocampal slices infected with pGIPZ-scramble or with pLKO-shRNF10. The histogram shows the
quantification of protein levels from shRNF10 samples with respect to pGIPZ-scramble, following normalization on tubulin (n=3, *p<0.05; **p<0.01;
unpaired Student’s t-test).
DOI: 10.7554/eLife.12430.006
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Figure 5. Heat map and gene ontology of differentially expressed genes identified in microarray experiments. (A)
Heat map of differentially expressed genes. Expression data are reported as log2 and blue color indicates high
expression values and red color low expression value. Sc represents the different scramble control (1–4), while Sh
represents the shRNA against RNF10 (5–8). (B) Gene ontology analysis of biological processes and enriched
pathways analysis of differentially regulated genes in absence of RNF10.
DOI: 10.7554/eLife.12430.007
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Figure 6. Activation of synaptic NMDARs triggers RNF10 translocation to the nucleus. (A) Hippocampal neurons
(DIV14) were incubated for 24 hr with 50 mM Bicuculline and 2.5 mM 4-AP (’Bic’) and immunolabeled for RNF10
(green) and PSD-95 (red). The histogram shows the quantification of RNF10 levels along dendrites 24 hr after
treatment (n=30, ***p<0.001; unpaired Student’s t-test); scale bar: 4 mm. (B,C) Bic treatment induces RNF10-tdEOS
translocation from distal dendrites to the nucleus in hippocampal neurons. (B) The histogram shows a significant
increase in RNF10-tdEOS photoconverted fluorescent intensities in the nucleus following Bic treatment (n=6;
p<0.05 Bic vs. control, from 40’ to 90’; unpaired Student’s t-test). (C), left panels: Baseline confocal image of
RNF10-tdEOS expressing hippocampal neuron illuminated sequentially with 488 nm and 555 nm laser excitation
wavelengths showing no emitted signal in the red spectra (ex555nm; left panels). Distal dendrite (ROI) selected for
photoconversion was illuminated with UV laser (405 nm wavelengths) repetitively through the image z-stack. (C),
right panels: Depicted are confocal max intensity projection images at respective time points in control after Bic
treatment or in control (untreated) neurons; scale bar: 20 mm. (D) Hippocampal neurons (DIV14) were treated with
Bic in presence of the GluN2A inhibitor NVP-AAM007 at different concentrations (50 and 300 nM), immunolabeled
for RNF10 (green) and stained with Dapi (blue). The histogram shows the quantification of RNF10 integrated
Figure 6 continued on next page
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dendrites as compared to untreated neurons, without affecting PSD-95 (Figure 6A) labeling and
induced a significant increase in RNF10 nuclear staining (Figure 6D, left panels). This effect was not
correlated to an alteration of RNF10 total protein amount as determined by WB analysis performed
with neuronal lysates (data not shown; +7.8% ± 8.6%, cLTP vs. control; p>0.05, n=6). To further con-
firm that RNF10 accumulates in the nucleus following long-distance protein transport, we performed
time-lapse confocal imaging of RNF10 fused to photoconvertible tdEOS (Figure 6B,C). We photo-
converted RNF10-tdEOS in distal dendrites from green-to-red emission using 405 nm irradiation
immediately after Bic treatment and tracked the red fluorescence signal over 90 min. Bic treatment
induced a significant increase in RNF10-tdEOS photoconverted fluorescence intensity in the nucleus
compared to untreated neurons accompanied by a decline in distal dendrites (Figure 6B–C).
Interestingly, the co-incubation of Bic with the GluN2A-specific inhibitor NVP-AAM007 (NVP,
50 nM or 300 nM) led to a significant reduction of RNF10 nuclear accumulation compared to Bic
treatment alone also at a concentration of 50 nM, which is known to preferentially block di-hetero-
meric GluN1/GluN2A and not tri-heteromeric GluN1/GluN2A/GluN2B NMDARs (Figure 6D;
Foster et al., 2010). Similarly, Bic dependent increase in RNF10 nuclear staining was reduced by the
co-incubation with the NMDAR blocker MK801 (data not shown). Moreover, hippocampal neurons
(DIV14) were treated with Bicuculline (50 mM) and 4-AP (2.5 mM) in presence of the GluN2B antago-
nist ifenprodil (5 mM), corresponding to a well-validated protocol to obtain a specific activation of
synaptic NMDARs (Syn; Figure 6E, left panel; Hardingham et al., 2002). Synaptic NMDARs stimula-
tion induced a significant increase in RNF10 nuclear accumulation (Figure 6E, left panels). On the
other hand, two different protocols known to activate extrasynaptic NMDARs (Hardingham et al.,
2002; Karpova et al., 2013) failed to induce the translocation of RNF10 from dendrites to the
nucleus (Figure 6E, right panel). In control experiments, we found that enhanced synaptic activity
with Bicuculline (50 mm) and 4-AP (2.5 mM) resulted in an increase in nuclear Jacob as reported pre-
viously (Figure 6F; Behnisch et al., 2011; Karpova et al., 2013). This increase was abolished in the
presence of the GluN2B antagonist ifenprodil (5 mM), but not with GluN2A antagonist NVP-AAM077
(50 nM) indicating that Jacob dissociates from the synapses following activation of GluN2B but not
di-heteromeric GluN2A containing NMDAR (Figure 6F).
Neuronal activity modulates RNF10 interaction with protein partners
The import of proteins from the cytosol into the nucleus through the nuclear pore complex depends
on the binding of importins to a specific nuclear localization sequence (NLS; Thompson et al., 2004;
Jordan and Kreutz, 2009; Karpova et al., 2012). According to this scheme, importins function as
adapter molecules by binding NLS-bearing proteins. Components of the classical nuclear import
machinery are present at synapses in association with NMDARs and importins translocate to the
nucleus in response to NMDAR stimulation (Thompson et al., 2004; Jeffrey et al., 2009;
Marfori et al., 2011; Ch’ng et al., 2012). Analysis of the RNF10 sequence showed the presence of
two putative NLS motifs (NLS1: aa 591–599; NLS2: aa 784–791; Seki et al., 2000; Marfori et al.,
2011). We therefore investigated the neuronal localization of RNF10 by transfection of RNF10 FL
and RNF10 truncated mutants lacking one [Myc-RNF10 (1–611)] or both NLS motifs [Myc-RNF10 (1–
Figure 6 continued
density in the nucleus expressed as % of control neurons (n=10, ***p<0.001 control vs Bic, Bic vs Bic+NVP 50 nM
and Bic vs Bic+NVP 300 nM; one-way ANOVA followed by Bonferroni post-hoc test); scale bar: 10 mm. (E)
Hippocampal neurons (DIV14) treated with ’Syn’ (50 mM Bicuculline; 2.5 mM 4-AP; 5 mM Ifenprodil, 8 hr), with
’Extrasyn#1’ or ’Extrasyn#2’ protocols (see Materials and methods), immunolabeled for RNF10 (green) and stained
with Dapi (blue). Histogram showing the quantification of RNF10 integrated density in the nucleus expressed as %
of control neurons (n=8, *p<0.05 Extrasyn#2 vs Syn, **p<0.01 Syn vs Extrasyn#1 and Syn vs. control; one-way
ANOVA followed by Bonferroni post-hoc test); scale bar: 10 mm. (F) Depicted are representative laserscans
averaged from three confocal sections of the nucleus of DIV16 hippocampal primary neurons immunolabeled with
affinity purified antibodies against pan-Jacob (rabbit) and co-labeled with anti-MAP2 antibodies as a neuronal
specific marker. Neuronal nuclei are outlined with the DNA stain Hoechst 34580. Scale bar: 10 mm. Relative
fluorescence intensities of Jacob 30 min of synaptic stimulation with and without selective inhibitors were
normalized to untreated non-stimulated control (n=31–70, ***p<0.001; one-way ANOVA followed by Bonferroni
post-hoc test).
DOI: 10.7554/eLife.12430.008
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Figure 7. RNF10 translocates into the nucleus through NLS2-dependent interaction with importin a1. (A) Confocal images of primary hippocampal
neurons transfected with Myc-RNF10 full-length (FL) or Myc-RNF10 truncated mutants and immunolabeled for Myc (green) and Dapi (blue); scale bar:
20 mm. (B) Primary hippocampal neurons transfected with Myc, Myc-RNF10 (1–611), pGIPZ-scramble or with shRNF10 were immunolabeled (DIV14) for
PSD-95. The histograms show the quantification of PSD-95-positive puncta expressed as % of Myc (upper histogram) or scramble (lower histogram)
transfected neurons (n=50–88, ***p<0.001, Myc-RNF10 (1–611) vs Myc and shRNF10 vs scramble; unpaired Student’s t-test); scale bar: 4 mm. (C)
Confocal images of dendrites of hippocampal neurons (DIV14) immunolabeled for RNF10 (red), surface GluN2A (green) and importin a1 (blue); scale
bar: 4 mm. (D) Importin a1 and PSD-95 protein levels were analyzed by means of WB analysis in various subcellular compartments purified from rat
hippocampal tissue (H: Homogenate fraction, S1: supernatant 1, P1: nuclear fraction, S2: cytosolic fraction 2, P2: crude membrane fraction 2, Syn:
synaptosomal fraction, PSD1: Triton insoluble postsynaptic fraction, PSD2: postsynaptic density fraction). (E) Representative co-i.p. assay showing the
Figure 7 continued on next page
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590)] in primary hippocampal neurons. Myc-RNF10 FL showed an intense nuclear accumulation (as
the endogenous protein; Figure 7A). However, both truncated mutants failed to localize to the
nucleus as indicated by a very low co-localization with the nuclear marker Dapi (Figure 7A). In partic-
ular, also the longest Myc-RNF10 (1–611) construct lacking only the C-terminal NLS2 domain accu-
mulated in the cell soma but did not show a marked nuclear localization (Figure 7A), thus
suggesting that the second NLS2 motif could be responsible for RNF10 nuclear translocation in neu-
rons. Notably, the overexpression of Myc-RNF10 (1–611) construct produced a significant reduction
in the density of PSD-95-positive puncta along dendrites (Figure 7B, upper panels) similar to that
observed following RNF10 silencing (Figure 7B, lower panels), indicating that this protein fragment
can act in a dominant negative manner.
Based on these results, we next evaluated a possible RNF10 interaction with importins in hippo-
campal neurons. RNF10 displayed a prominent co-localization with importin a1 (KPNA2 gene prod-
uct; see Zienkiewicz et al., 2013) and surface GluN2A along dendrites of DIV14 primary
hippocampal neurons (Figure 7C). In agreement with previous data about other importins
(Thompson et al., 2004; Jeffrey et al., 2009; Marfori et al., 2011; Ch’ng et al., 2012), analysis of
importin a1 subcellular distribution showed its presence in purified PSDs from rat hippocampus
(Figure 7D). Immunoprecipitation experiments performed revealed that RNF10 interacts with impor-
tin a1 in neuronal cells (Figure 7E, upper panel). Interestingly, RNF10 co-precipitation with importin
a1 was detected both in PSD and homogenate fraction but it was much more prominent in PSDs
(Figure 7E, lower panel). In order to verify the capability of RNF10 to interact also with other impor-
tins, we performed heterologous co-immunoprecipitation experiments of RNF10 fused to GFP with
six importin a isoforms (KPNA1-KPNA6 gene products) fused to tag-RFP. As shown in Figure 7F,
RNF10 can interact with majority of importin a isoforms except importin a3 (KPNA4 gene product).
Bic treatment significantly increased RNF10/importin a1 association (Figure 7G). Interestingly,
also the RNF10 interaction with the transcription factor Meox2 was significantly increased by Bic
treatment (Figure 7H). On the contrary, Bic treatment significantly decreased RNF10/GluN2A inter-
action compared to control neurons (Figure 7H), which is in agreement with the reduction of RNF10
labeling along dendrites (see Figure 6A).
Taken together these findings indicate that enhancing synaptic activity of di-heteromeric
GluN2A-containing NMDARs results in the dissociation of RNF10 from the cytoplasmic tail of
GluN2A at postsynaptic sites and a tighter association with neuronal importin and importin-depen-
dent nuclear translocation, followed by an association of RNF10 with the transcription factor Meox2.
RNF10 nuclear translocation is mediated by LTP induction
LTP is widely considered as one of the major cellular mechanisms that underlie learning and memory
(Bliss and Collingridge, 1993) and requires de novo protein synthesis and gene transcription for its
maintenance (Smolen et al., 2012). We next asked whether RNF10 translocates to the nucleus from
distal dendrites following induction of LTP in mature hippocampal neuronal cultures. For induction
of LTP we used two established protocols (Deisseroth et al., 1996; Otmakhov et al., 2004;
Oh et al., 2006). First, we employed 18s@50Hz field stimulation, which is known to produce a stable
synaptic potentiation in cultured hippocampal neurons (Deisseroth et al., 1996) and in parallel we
performed time-lapse confocal imaging of RNF10 fused to photoconvertible tdEOS (Figure 8A–C).
The rise in intracellular Ca2+ concentration upon LTP-inducing stimuli was verified by Fluo-4-AM fluo-
rescence (data not shown). We photoconverted RNF10-tdEOS in distal dendrites (Figure 8A) and
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interaction between RNF10 and importin a1 in hippocampal tissue homogenate (upper and lower panel) and PSD fraction (lower panel). No Ab lane:
control lane in absence of the antibody. WB analysis was performed with RNF10 and importin a1 antibodies. (F) RNF10-tagged with GFP was co-
expressed with multiple importin a isoforms (KPNA1-KPNA6) tagged with tagRFP in HEK293T cells. RNF10-GFP was immunoprecipitated from cell
extract using anti-GFP MicroBeads. Co-immunoprecipitated importinerase - a isoforms were detected in complex with RNF10 using anti-tagRFP
antibodies. (G) Co-i.p. assay performed by using an importin a1 antibody from cell homogenates of control (C) neurons or treated with Bic. WB analysis
was performed with RNF10 antibody. The histogram shows the quantification of RNF10/importin a1 interaction expressed as % of control (n=3,
*p<0.05; unpaired Student’s t-test). (H) Representative co-i.p. assay from cell homogenates of control (C) neurons or treated with Bic. WB analysis was
performed with RNF10 antibody. The histogram shows the quantification of RNF10 interaction with GluN2A and Meox2 expressed as % of control (n=3,
***p<0.001, Meox2, Bic vs control; **p<0.01, GluN2A, Bic vs control; unpaired Student’s t-test).
DOI: 10.7554/eLife.12430.009
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Figure 8. LTP induction triggers RNF10 translocation to the nucleus. (A–C) RNF10-tdEOS translocates from distal
dendrites to the nucleus in mature hippocampal neurons upon high-frequency 18s@50Hz field synaptic
stimulation. Distal dendrites (ROIs) selected for photoconversion were illuminated with UV laser (405 nm
wavelengths) repetitively through the image z-stack (image t0‘). (A) Representative images of control and
stimulated RNF10-tdEOS expressing hippocampal neurons illuminated with 568 nm laser excitation wavelength 1
min following photoconversion. (B) The histogram shows a significant increase in RNF10-tdEOS photoconverted
fluorescent intensities in the nucleus following high frequency 18s@50Hz field synaptic stimulation (n=9, *p<0.05,
**p<0.01, ***p<0.001; unpaired Student’s t-test). (C) Depicted are confocal max intensity projection images of
control and stimulated RNF10-tdEOS expressing hippocampal neurons at respective time points after stimulation.
Lower panels: magnified image sequence of UV illuminated dendritic segment with multiple spines is represented
showing the decrease in distal dendrites upon field stimulation. All experiments were performed in a presence of
anisomycin (7.5 mM). (D) Confocal images of dendrites of hippocampal neurons (DIV14) transfected with GFP
Figure 8 continued on next page
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tracked the red fluorescence signal over time. We observed a significant increase in RNF10-tdEOS
photoconverted green-to-red fluorescence intensity in the nucleus when compared to unstimulated
neurons (Figure 8B,C) accompanied by a concomitant decline in distal dendrites upon stimulation
(Figure 8C, lower panels). This emphasizes that the synaptodendritic but not the somatic pool of
RNF10 largely contributes to its nuclear transport upon LTP-inducing stimuli. Thus, RNF10 accumu-
lates in the nucleus following long-distance protein transport.
We next used a validated chemical LTP (cLTP) protocol (Otmakhov et al., 2004; Oh et al.,
2006), which is known to activate synaptic NMDARs in primary hippocampal neurons. As expected,
induction of cLTP leads to an increase of CREB-Ser133 (P-CREB; Bito et al., 1996) and GluA1-
Ser845 (P845-GluA1; Marcello et al., 2013) phosphorylation (data not shown). Under these experi-
mental conditions, cLTP induction produced a significant decrease in endogenous RNF10 immunos-
taining along dendrites (Figure 8D) and a concomitant significant increase of RNF10 localization in
the nucleus as revealed by western blotting in a crude nuclear fraction (Figure 8G) and co-localiza-
tion assays with the nuclear marker Dapi (Figure 8F and Figure 9B). Consistent with the above-
described results (see Figure 7H), cLTP detached RNF10 from GluN2A (Figure 8E). These effects
were not correlated to an alteration of RNF10 total protein abundance as determined by WB analysis
performed with neuronal lysates (data not shown; +9.5% ± 8.7%, cLTP vs. control; p>0.05, n=8).
Finally, we used anisomycin to exclude the possibility that de novo RNF10 protein synthesis could
account for the nuclear accumulation of RNF10 following cLTP (Figure 8F,G). Anisomycin treatment
did not prevent nuclear accumulation of RNF10 in this assay (Figure 8F,G).
The RNF10 (1–611) protein fragment, lacking the NLS2 motif, fails to localize to the nucleus
(Figure 7A). Taking this into account, we induced cLTP in the presence of an exogenously added
RNF10 NLS2 peptide, thus competing with endogenous RNF10/importin binding. RNF10 NLS2 pep-
tide is mostly composed of basic residues having a very high similarity with the most common cell-
permeable peptides (CPPs) such as the TAT peptide (Farkhani et al., 2014). However, before the
evaluation of the effect of NL2 peptide on RNF10 subcellular distribution, we first verified the ability
of this peptide to act as a CPP, that is, that it can cross the plasma membrane and enter neurons. As
shown in Figure 9A, we detected TideFluorTM-tagged TAT and NLS2 peptides into neurons to a
similar extent, thus indicating the capability of the NLS2 peptide to work as a CPP. Notably, NLS2
peptide induced a significant reduction of RNF10/importin a1 interaction when compared to treat-
ment with TAT (used as control peptide; Figure 9B). The NLS2 peptide completely prevented the
LTP-dependent increase in nuclear RNF10, as indicated by immunofluorescence (Figure 9C,D) and
by immunoblot analyses of RNF10 protein levels in a P1 crude nuclear fraction (Figure 9G,H). Impor-
tantly, treatment with NLS2 peptide also prevented the decrease in dendritic RNF10 labeling
observed after induction of cLTP (Figure 9E,F). Overall, these results further confirm that NLS2-
dependent binding to importin represents a key step for RNF10 trafficking to the nucleus.
Conversely, induction of chemical long-term depression (cLTD) did not modify RNF10 binding to
GluN2A (Figure 9I; +0.9% ± 4.8%, cLTD vs. control; p>0.05) and the nuclear distribution of RNF10
in hippocampal neurons (Figure 9J).
Figure 8 continued
(green) to visualize neurites and immunolabeled for RNF10 (red) and PSD-95 (blue). The histogram shows the
quantification of RNF10 signal in dendrites 2 hr after induction of cLTP (see Materials and methods) expressed
as % of control (n=5, **p<0.01; unpaired Student’s t-test); scale bar: 4 mm. (E) Co-i.p. assay from hippocampal
extracts performed with an antibody against GluN2A. WB analysis was performed using antibody for RNF10 and
GluN2A. The graph shows the effect of cLTP induction on RNF10 interaction with GluN2A expressed as % of
control (n=4, ***p<0.001; unpaired Student’s t-test). (F) Representative confocal images of hippocampal neurons
(DIV14) after the induction of cLTP in the presence or absence of 7.5 mM anisomycin and immunolabeled for
RNF10 (green) and Dapi (blue); scale bar: 10 mm. (G) WB analysis for RNF10 from P1 nuclear fraction purified from
hippocampal neurons after the induction of cLTP in the presence or absence of 7.5 mM anisomycin. The histogram
shows the quantification of RNF10 integrated density normalized on Histone-H3 (n=4, *p<0.05, control vs cLTP
and control vs cLTP+Anisomycin; one-way ANOVA, followed by Tukey post-hoc test).
DOI: 10.7554/eLife.12430.010
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Figure 9. NLS2 peptide but not anysomicin blocks RNF10 accumulation in the nucleus after induction of cLTP. (A) Confocal images from living
hippocampal neurons transfected with dTomato (DIV10) and treated with TAT-TF2 or NLS2-TF2 coniugated peptide (DIV14). Samples were illuminated
with 543 nm and 488 nm to visualize respectively neurons and peptide. The representative image shows the presence of peptide (green) within the
neuron (red, DTOMATO), demonstrating the capability of crossing the plasmatic membrane; scale bar: 10 mm. (B) Representative co-i.p. assay
performed by using anti-RNF10 antibody and showing the interaction between RNF10 and importin a1 in primary hippocampal neurons (DIV14) treated
with NLS2 peptide (active) or TAT (control) peptide. No IgG lane: control lane in absence of the antibody. WB analysis was performed with importin a1
and RNF10 antibodies. The histogram shows the quantification of importin a1 interaction with RNF10 expressed as % of control (TAT; n=3; *p<0.05;
unpaired Student’s t-test). (C, E) Hippocampal neurons (DIV14) were treated with NLS2 peptide (active) or TAT (inactive) peptide for 24 hr and then
cLTP was induced in the presence of the same peptides. Confocal images show the immunolabeling for RNF10 (green) and the staining for Dapi (blue)
in the nucleus (C) or PSD-95 (red) along dendrites (E); scale bars: 10 mm (C) and 4 mm (E). (D, F) The histograms show the quantification of RNF10 signal
in the nucleus (D) and along dendrites (F) after the induction of cLTP in the presence of TAT or NLS2 peptides expressed as % of control [n=10,11 (D),
n=17–19 (F)]; *p<0.05; **p<0.01; *p<0.001; one-way ANOVA, followed by Tukey post-hoc test). (G, H) WB analysis for RNF10 from P1 crude nuclear
fraction purified from hippocampal neurons after the induction of cLTP in the presence of NLS2 or TAT peptide (G). The histogram (H) shows the
quantification of RNF10 integrated density normalized on Histone-H3 and expressed as % of control (n=4, *p<0.05; one-way ANOVA, followed by
Tukey post-hoc test). (I) Representative co-i.p. assay performed with an antibody against RNF10 from cell lysates of hippocampal neurons following
induction of cLTD. WB analysis was performed using antibody for RNF10 and GluN2A. (J) Confocal images of the soma of hippocampal neurons
(DIV14) treated with a protocol to induce cLTD and then immunolabeled for RNF10 (green) and stained with Dapi (blue). Scale bar: 10 mm.
DOI: 10.7554/eLife.12430.011
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RNF10 translocation to the nucleus regulates the expression of specific
target genes
We next asked whether RNF10 translocation from dendritic spines to the nucleus produced a modu-
lation of the protein level of Meox2/RNF10 target genes. First, we analyzed the expression of
p21WAF1/cip1, a known Meox2 target gene (Lin et al., 2005; Malik et al., 2013). Bic treatment
increased p21WAF1/cip1 levels as evaluated by immunofluorescence (Figure 10A,B) and Western blot
analysis (Figure 10C). Up-regulation of p21WAF1/cip1 was significantly attenuated by co-treatment
with the NMDAR blocker MK801 (Figure 10A–C). Similarly, stimulation of synaptic NMDARs induced
an increase in p21WAF1/cip1 that was blocked by bath application of MK801 (Figure 10D). Notably,
the increase in p21WAF1/cip1 protein levels following stimulation of synaptic NMDARs was completely
prevented by RNF10 silencing (Figure 10E), indicating that modulation of p21WAF1/cip1 expression is
RNF10-dependent. In addition, the same effect on p21WAF1/cip1 levels was observed following induc-
tion of cLTP. Again, the increased expression of p21WAF1/cip1 was prevented by RNF10 silencing
(Figure 10F). Finally, RNF10 silencing decreased the expression of the newly identified RNF10 target
gene Ophn1 (see Figure 4G,H) also after synaptic stimulation (Figure 10G).
Altogether these results indicate that stimulation of synaptic NMDARs or induction of LTP leads
to RNF10 translocation to the nucleus, where it binds to Meox2 and stimulates the expression of
RNF10/Meox2 target genes (Lin et al., 2005; Malik et al., 2013), such as p21WAF1/cip1 and Ophn1.
Down-regulation of RNF10 expression prevents cLTP expression
We finally analyzed whether RNF10 silencing leads not only to a decrease of dendritic spine density
(Figure 4A–E) but also to an alteration of the plastic properties of synapses. To this end, we
recorded miniature EPSCs (mEPSCs) in hippocampal neurons before and for 2 hr after cLTP induc-
tion. In basal conditions, down-regulation of RNF10 led to a significant decrease of the frequency
(Figure 11A,C) but not the amplitude (Figure 11A,B) of mEPSCs. Notably, no alteration of mEPSCs
frequency was observed by co-expressing shRNF10 with the wild-type human variant of RNF10 resis-
tant to shRNA (FlagRNF10; Figure 11A,C). Furthermore, while in control neurons cLTP induction
resulted in a long-lasting increase of the amplitude and frequency of mEPSCs, this effect was totally
prevented in neurons transfected with shRNF10 (Figure 11D,E). Again, co-transfection of FlagRNF10
fully rescued a physiological long-lasting increase of the amplitude (Figure 11D) and frequency
(Figure 11E) of mEPSCs.
We then tested whether different levels of RNF10 expression could affect not only spine density
(see Figure 4A–E) but also interfere LTP-dependent modulation of dendritic spine size (Bosch and
Hayashi, 2012). To this end, we overexpressed or silenced RNF10 in hippocampal neurons (DIV7)
followed by induction of cLTP (DIV14). As expected, cLTP increased significantly PSD-95 cluster
width in control neurons (Figure 11F,G). RNF10 overexpression produced an increase in PSD-95
clusters width also in absence of stimulation and occluding any further increase of PSD-95 clusters
width following induction of cLTP (Figure 11F). On the other hand, RNF10 silencing blocked any
cLTP-dependent modification of PSD-95 clusters (Figure 11G). Evaluation of GluA1 synaptic cluster
size confirmed that RNF10 silencing precludes any increase in GluA1 clusters width induced by cLTP
(Figure 11I).
Discussion
This report describes a novel synapse-to-nucleus signaling pathway that specifically links activation
of synaptic GluN2A-containing NMDARs to nuclear gene expression. We demonstrate that RNF10 is
highly expressed in the nucleus as well as at synapses, where it is part of the NMDAR complex
and directly interacts with the cytoplasmic tail of the GluN2A subunit of NMDARs. RNF10 dissociates
from the NMDAR complex in an activity-dependent manner and we provide compelling evidence for
the importin-dependent long-distance transport from synapto-dendritic compartments to the
nucleus.
The intracellular C-terminal domain of GluN2A contains several target sequences for downstream
signaling and scaffolding molecules (Sanz-Clemente et al., 2013; Sun et al., 2016). Among others,
RNF10 and CaM share the same GluN2A binding region (aa 991–1029; Bajaj et al., 2014). Our
results indicate a preferential formation of RNF10/GluN2A complex in resting conditions that is
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disrupted in favor of CaM/GluN2A complex following synaptic activity-dependent calcium influx.
Overall, our data show that RNF10 binding to GluN2A plays a key role for RNF10 anchoring at the
excitatory synapse but also interfere with the formation of CaM/NMDAR complex. Moreover, the
presence of RNF10 in close proximity to the receptor channel allows for a rapid calcium-dependent
Figure 10. RNF10 nuclear trafficking regulates the expression level of specific target genes. (A) Hippocampal neurons (DIV14) were treated with Bic in
the presence or absence of MK801, immunolabeled for MAP2 (red), p21WAF1/cip1 (green) and stained with Dapi (blue); scale bar: 10 mm. (B) Histogram
showing the quantification of p21WAF1/cip1 signal in the nucleus expressed as % of control (n=15, ***p<0.001 Bic vs control and Bic+MK801 vs Bic; one-
way ANOVA, followed by Bonferroni post-hoc test). (C) WB analysis from cell lysates of hippocampal neurons treated with Bic in presence or absence of
MK801. The histogram shows the quantification of p21WAF1/cip1 integrated density normalized on tubulin (n=5, **p<0.01 Bic vs control and Bic+MK801
vs Bic; one-way ANOVA, followed by Bonferroni post-hoc test). (D) WB analysis for p21WAF1/cip1 and tubulin performed on cell lysates from DIV14
hippocampal neurons treated for synaptic stimulation (Syn; see Materials and methods) in the presence or absence of MK801. The histogram shows the
quantification of p21WAF1/cip1 levels normalized on tubulin (expressed as integrated density) (n=5, **p<0.01, Syn vs control; *p<0.05 Syn+MK801 vs Syn;
one-way ANOVA, followed by Bonferroni post-hoc test). (E) WB analysis for RNF10, p21WAF1/cip1 and tubulin performed on cell lysates from
hippocampal neurons virally infected with pLKO-shRNF10 or control vector and treated at DIV14 for Syn. The histogram shows the effect of RNF10
silencing on p21WAF1/cip1 expression levels normalized on tubulin (n=4, *p<0.05, Syn vs control and Syn+shRNF10 vs Syn; one-way ANOVA, followed by
Bonferroni post-hoc test). (F) WB analysis for p21WAF1/cip1 and tubulin from hippocampal extracts following induction of cLTP in the presence or
absence of viral infection with pLKO-shRNF10. The graph shows the modulation of p21WAF1/cip1 levels (following normalization on tubulin) (n=5,
*p<0.05, cLTP vs control, **p<0.01, cLTP + pLKO-shRNF10 vs cLTP; one-way ANOVA, followed by Bonferroni post-hoc test). (G) WB analysis for Ophn1
and tubulin performed on cell lysates from hippocampal neurons virally infected with pLKO-shRNF10 or control vector and treated at DIV14 for Syn.
The histogram shows the effect of RNF10 silencing on Ophn1 expression levels normalized on tubulin (n=3, *p<0.05, Syn+shRNF10 vs Syn; one-way
ANOVA, followed by Bonferroni post-hoc test).
DOI: 10.7554/eLife.12430.012
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Figure 11. Down-regulation of RNF10 expression prevents cLTP expression. (A) mEPSCs recorded at -60 mV before (basal), and after cLTP induction in
hippocampal neurons transfected or not (CT) with shRNF10 or with shRNF10 + FlagRNF10. (B, C) Basal amplitude (B) and frequency (C) of mEPSCs,
prior cLTP induction (**p<0.01, shRNF10 vs CT). (D, E) Time-course of amplitude (D) and frequency (E) of mEPSC following cLTP induction (*p<0.05,
shRNF10 vs CT). (F, H) Effects of RNF10 overexpression on cLTP-induced modifications of dendritic spine morphology. Confocal images of
hippocampal neuron dendrites (DIV14) transfected at DIV7 with GFP or GFP-RNF10, treated for cLTP induction and immunolabeled for PSD-95 (F) or
GluA1 (H); scale bar: 4 mm. The histograms show the quantification of PSD-95 (F) and GluA1 (H) clusters width (PSD-95: n=6, ***p<0.001; GluA1: n=8–
10, *p<0.05; one-way ANOVA, followed by Bonferroni post-hoc test). (G, I) Effects of RNF10 silencing on cLTP-induced modifications of dendritic spine
morphology. Confocal images of hippocampal neuron dendrites (DIV14) transfected at DIV7 with scramble sh or shRNF10, treated for cLTP induction
and immunolabeled for PSD-95 (G) or GluA1 (I); scale bar: 4 mm. The histograms show the quantification of PSD-95 (G) and GluA1 (I) clusters width
(PSD-95: n=6, ***p<0.001; GluA1: n=8–10, ***p<0.001; one-way ANOVA, followed by Bonferroni post-hoc test).
DOI: 10.7554/eLife.12430.013
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dissociation of RNF10/GluN2A complex following NMDAR activation and for the subsequent forma-
tion of RNF10/importin complex.
Here, we show that interaction of RNF10 with importin a1 represents a key step for its nuclear
translocation. However, we also describe that RNF10 can interact with the majority of importin a iso-
forms including the importin a5 previously described to be associated with the NMDAR complex
(Jeffrey et al., 2009). Taken together, these findings suggest that synaptonuclear trafficking of
RNF10 is involved in the control of gene expression, which is necessary for LTP-type synaptic plastic-
ity in hippocampal neurons. Very few studies are available addressing the role of RNF10 in the CNS,
and they mainly address its association with the transcription factor Meox2, which regulates cell pro-
liferation and differentiation (Seki et al., 2000; Lin et al., 2005; Hoshikawa et al., 2008;
Malik et al., 2013). A very recent study performed in P19 carcinoma cell line and in mouse cerebel-
lar granule cells suggests that RNF10 acts as a positive regulator of neuronal differentiation, as its
knockdown reduced the number of cells expressing early and late neuronal markers (Malik et al.,
2013). Notably, microarray, subsequent real-time PCR and western blotting analysis allowed us to
find, among others, novel RNF10 target genes known to be involved in the regulation of the excit-
atory synapse function and morphology (Vogt et al., 2007; Michaluk et al., 2011; Bagni et al.,
2012; Ramakers et al., 2012; Pavlowsky et al., 2012). RNF10 silencing induced a dramatic up-reg-
ulation of MMP9 expression and a concomitant reduction of Arhgef6, ArhGap4 and Ophn1 levels.
Intriguingly, all these genes are mutated or dysregulated in intellectual disability syndromes in
humans and/or in the corresponding mouse models (Vogt et al., 2007; Michaluk et al., 2011;
Ramakers et al., 2012), which are characterized by various alterations in dendritic spines, thus sug-
gesting a key role in synaptic effects observed following RNF10 silencing. In this view, modulation of
RNF10 expression in hippocampal neurons demonstrated its relevant role in regulating dendritic
spine morphology under resting conditions as well as following activity-dependent plasticity. In par-
ticular, RNF10 silencing leads to a significant decrease in spine density that is fully rescued by co-
transfection of shRNA-resistant RNF10 construct. As a direct consequence of this dramatic morpho-
logical event, we also observe a concomitant reduction in the expression of proteins almost exclu-
sively localized at the excitatory PSD, such as PSD-95, AMPARs GluA1 subunit and NMDARs
GluN2A subunit. Notably, overexpression of the RNF10(1–611) construct unable to translocate to
nucleus leads to a significant reduction in PSD-95 positive puncta along dendrites. This result
strongly indicates that an impaired RNF10-mediated synaptonuclear signaling and not a reduction of
RNF10 synaptic levels is responsible for the reduction of dendritic spine density observed following
RNF10 silencing.
The present and other studies indicate that NMDAR complex is likely a very rich source of protein
messengers that are capable of trafficking to the nucleus. Most important, the present study pro-
vides convincing evidence that different NMDAR signals will indeed induce the nuclear import of dif-
ferent messengers. Several reports have documented that NMDARs activation leads to a differential
modulation of nuclear gene expression, depending upon their localization (Hardingham and Bad-
ing, 2010). In general, activation of synaptic NMDARs promotes the expression of synaptic plastic-
ity-related genes, whereas activation of extrasynaptic NMDARs has been correlated to CNS
pathological conditions (Hardingham and Bading, 2010). The protein messenger Jacob, following
long-distance transport and nuclear import, can encode and transduce the synaptic and extrasynap-
tic origin of GluN2B NMDAR signals to the nucleus and might dock a NMDA-receptor-derived sig-
nalosome to nuclear target sites in a stimulus-dependent manner (Karpova et al., 2013). Notably,
here we show that activation of synaptic but not extrasynaptic NMDARs leads to an increase in
RNF10 nuclear localization. Similarly to what was previously described for Jacob (Behnisch et al.,
2011), we observe that RNF10 moves to the nucleus after induction of LTP but not LTD, modulating
the expression of Meox2 target genes. However, in contrast to Jacob, inhibition of GluN2A- but not
GluN2B-containing NMDARs is sufficient to block RNF10 trafficking to the nucleus, its interaction
with the transcription factor Meox2 and the expression of the Meox2 target gene p21WAF1/cip1.
Another intriguing finding includes the observation that the transcription factor CREB2 also known
as ATF4 transits to the nucleus only after induction of NMDAR-dependent cLTD but not cLTP
(Lai et al., 2008). Transcriptional regulators at synaptic sites like CRTC1 can also be phosphorylated
by synaptic signals in a complex manner and translocation of CRTC1 to the nucleus might link spe-
cific types of stimuli to specific changes in gene expression.
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Overall our data together with the findings from other recent reports (Kaushik et al.,
2014; Rishal and Fainzilber, 2014; Panayotis et al., 2015), suggest that synapse-to-nucleus protein
transport provide specific ways to inform the nucleus about very different types of synaptic activity.
In this context, RNF10 represents a novel synaptonuclear protein messenger responsible for long-
lasting re-shaping of dendritic spines as observed after specific synaptic stimuli and required for
postsynaptic modifications needed to convey LTP induction.
Materials and methods
Purification of post-synaptic densities, triton insoluble postsynaptic
fractions and crude nuclear fractions
Post-synaptic densities (PSDs) from rat hippocampus were isolated as previously reported
(Gardoni et al., 1998). To purify the postsynaptic Triton-insoluble fraction (TIF), cell lysates were
centrifuged at 13,000 g for 15 min at 4˚C. The resulting pellet was resuspended in 150 mM KCl,
0.5% Triton and spun at 100000 g for 1 hr at 4˚C. The final pellet (TIF) was homogenized with a
glass-glass potter in 20 mM Hepes buffer containing Complete. All purifications were performed in
the presence of complete sets of protease and phosphatase inhibitors (Roche Diagnostics, Monza,
Italy) Protein content of the samples has been quantified by using Bio-Rad (Hercules, CA, USA) pro-
tein assay. After measuring protein concentration, all samples have been standardized at 1 mg/ml
concentration and the same protein amount loaded in each lane for western blot analysis.
Organotypic hippocampal slice, neuronal cultures, transfection and
treatments
Organotypic hippocampal slice cultures were prepared as previously described
(Pellegrini Giampietro et al., 1999). Hippocampal neuronal primary cultures were prepared from
embryonic day 18–19 (E18-E19) rat hippocampi as previously described (Piccoli et al., 2007). Neu-
rons were transfected at DIV7 using calcium-phosphate method. For induction of ’Bic’ treatment:
hippocampal neurons (DIV14) or organotypic hippocampal slices (DIV14) were incubated with Bicu-
culline (50 mM; Tocris) and 2.5 mM 4-Aminopyridine (4-AP;Tocris) in Neurobasal medium supple-
mented with B27; ’Syn’ treatment: stimulation of synaptic NMDA receptors was obtained by treating
hippocampal neurons at DIV14 with 50 mM Bicuculline (Tocris), 2.5 mM 4-AP and 5 mM ifenprodil in
Neurobasal medium supplemented with B27; ’Extrasyn#1’ treatment: stimulation of extrasynaptic
NMDA receptors was obtained by pretreating hippocampal neurons at DIV14 with 50 mM Bicucul-
line, 2.5 mM 4-AP and 10 mM MK801 for 30 min, washing them with Neurobasal medium supple-
mented with B27, incubating with 50mM KCl (Carlo Erba) for 10 min and then with 40 mM
Glutamate (Sigma); ’ExtraSyn#2’ treatment was performed as previously described by Karpova and
co-workers (2013). cLTP (Otmakhov et al., 2004; Oh et al., 2006): Primary neuronal cultures at
DIV14 were first incubated in ACSF (125 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 33 mM
D-glucose and 25 mM HEPES, pH 7.3) for 30 min, followed by 16 min of stimulation with 0.05 mM
Forskolin (Sigma Aldrich), 0.1 mM Picrotoxin (Tocris) and 100 nM Rolipram (Calbiochem) in ACSF (no
MgCl2) to induce NMDAR-dependent cLTP. Control was incubated in ACSF. After stimulation, neu-
rons were replaced in regular ACSF for 2 hr. cLTD (Marcello et al., 2013): primary neuronal cultures
at DIV14 were first incubated in ACSF, followed by incubation in ACSF (in presence of MgCl2) and
50 mM NMDA (Sigma Aldrich) for 10 min. Neurons were then replaced in regular ACSF for 1 hr to
induce cLTD. For treatment with ’NLS2 peptide’ hippocampal neurons (DIV14) were treated with
active (NLS2: RKRKRQKQK) or control (TAT: GRKKRRQRRRPQ) peptide for 24 hr and then treated
to induce cLTP the presence of the same peptides.
COS-7 and HEK293T experiments
COS-7 cells were maintained in DMEM + Glutamax medium (GIBCO-BRL) supplemented with 10%
Fetal Bovine Serum (FBS) (GIBCO-BRL) and Pen/Strep (GIBCO-BRL). The day before transfection,
COS-7 cells were placed in a 6 wells multiwell (for cells lysis) or 12 wells multiwell (for cells immunos-
taining), then cells were transfected using lipofectamine method (Invitrogen). After 36 hr, COS-7
cells were lysed for co-immunoprecipitation and western blotting or fixed for immunostaining.
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RNF10-tagged with GFP was co-expressed with importin a isoforms (KPNA1-KPNA6) tagged
with tagRFP in HEK293T cells. Thirty-six hours post-transfection proteins were extracted with RIPA
buffer containing phosStop (50 mM Tris pH=8, 1% NP-40, 0.5% NO deoxycholate, 0.1% SDS,
150 mM NaCl, 1% Triton X-100, protease inhibitor). RNF10-GFP was immunoprecipitated from cell
extract using anti-GFP MicroBeads (MACSMolecular). Co-immunoprecipitated importinerase-a iso-
forms were detected in complex with RNF10 using anti-tagRFP antibodies (Evrogen).
Gene expression and microarray
Real-time quantitative PCR (qPCR) was performed as previously described (De Fabiani et al., 2003).
The following gene expression assay kits from Life Technologies have been used: Rn01409258_g1
for S100a11; Rn01504461_g1 for Rac2; Rn01526492_m1 for Apbb1ip; Rn01422083_m1 for Il18;
Rn01430875_g1 for Timp1; Mm00623991_m1 for Itgb8; Rn01513693_m1 for Thbs1;
Rn00580728_m1 for Cd36; Rn00579162_m1 for Mmp9. For microarray experiments, RNA was ana-
lyzed by the Genopolis Consortium using an Affimetrix platform (GEO accession number
GSE69267). Data was primarily analyzed using the TAC and Partek Genomic suite softwares. The
Robust Multichip Average (RMA) method was employed to calculate probe set intensity
(Irizarry et al., 2003). Differentially-expressed genes whose fold change was higher or equal than
1.75 (up-regulated genes) and lower or equal to 0.65 (down-regulated genes) with a p value lower
than 0.05 were selected as significantly modulated. The expression value of each probe is divided by
the mean value of the scramble controls and the log2 of this ratio has been reported. Gene Ontol-
ogy biological process and enriched pathways analyses were performed using Panther software
(http://www.pantherdb.org/).
Co-immunoprecipitation assays (co-i.p.)
Hippocampi from adult rats were homogenized at 4˚C in an ice-cold buffer containing 0.32 M
Sucrose, 1 mM Hepes, 1 mM NaF, 0.1 mM PMSF, 1 mM MgCl in presence of protease inhibitors
(Complete, GE Healthcare, Mannheim, Germany) and phosphatase inhibitors (PhosSTOP, Roche
Diagnostics GmbH, Mannheim, Germany), using a glass-Teflon homogenizer. Homogenates were
then centrifuged at 1000 g for 5 min at 4˚C, to remove nuclear contamination and white matter. The
supernatant was collected and centrifuged at 13,000 g for 15 min at 4˚C. The resulting pellet was
resuspended in hypotonic buffer (1 mM Hepes with Complete) and referred as P2 crude membrane
fraction. Aliquots of proteins from homogenate, P2 crude membrane fractions or PSDs were incu-
bated overnight at 4˚C in RIPA buffer containing 50mM Tris HCl (pH 7.2), 150 mM NaCl, 1% NP-40,
0.5% deoxycholic acid, 0.1% sodium dodecyl sulphate (SDS) in a final volume of 150 ml with the anti-
body. Pre-incubation with 1% SDS was used for co-i.p. experiments performed in PSDs
(Gardoni et al., 2001). As a control, one sample was incubated in the absence of the antibody (no
IgG lane) and another sample in presence of an irrelevant antibody. Protein A-sepharose beads
(Sigma-Aldrich) were added and incubation was continued for 2 hr, at room temperature, with shak-
ing. Beads were collected by centrifugation and washed three times with RIPA buffer before adding
sample buffer for SDS-PAGE and boiling for 5 min. Beads were collected by centrifugation, all super-
natants were applied onto 7%–12% SDS-PAGE and revealed by western blotting.
In situ proximity ligation assay (PLA)
PLA was performed as previously described (So¨derberg et al., 2006; Augusto et al., 2013) in pri-
mary hippocampal neurons. Cells were fixed with 4% PFA - 4% Sucrose for 5 min at 4ºC. Cells were
then rinsed in PBS, permeabilized with 0.1% Triton X-100 in PBS for 15 min at room temperature
and blocked with 5% BSA in PBS for 30 min at room temperature. Subsequently, cells were incu-
bated with goat polyclonal anti-RNF10 antibody (1:200; Santa-Cruz) and rabbit polyclonal anti-
GluN2A antibody (1:200; Lifetechnologies) overnight at 4ºC. After washing in PBS, the cells were
incubated for 1 hr at 37ºC with the PLA secondary probes anti-goat Plus and anti-rabbit Minus (Olink
Bioscience). Afterward, the cells were washed twice with Duolink II Wash Buffer A (Olink Bioscience)
and incubated with the ligation-ligase solution (Olink Bioscience) for 30 min at 37ºC. After a new
rinse, the cells were incubated with DNA polymerase (1:80; Olink Bioscience) in the amplification
solution (Olink Bioscience) for 100 min at 37˚C. After washes in consecutive decreasing concentra-
tions with Duolink II Wash Buffer B (Olink Bioscience), the cells were then incubated with chicken
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polyclonal anti-GFP/rabbit polyclonal anti-MAP2 (1:300/1:400; Milipore/Milipore) overnight at 4ºC.
After washing in PBS, the cells were incubated for 1 hr at room temperature with secondary goat
anti-chicken-AlexaFluor 488/goat anti-rabbit-AlexaFluor 647 (Lifetechnologies). The cells were
washed with PBS and mounted on slides with Fluoroshield mounting medium (Sigma).
Cloning, expression, and purification of glutathione S-transferase (GST)
fusion protein
The C-terminal tail of the GluN2A subunit was subcloned downstream of glutathione S-transferase
(GST) in the BaMHI and HindIII sites of the expression plasmid pGEX-KG by PCR using the Pfu poly-
merase (Stratagene) on a GluN2A cDNA template (kind gift from S. Nakanishi). GST-GluN2A fusion
proteins containing the cytoplasmic domain of GluN2A (839–1464 or 1049–1464 or 1244–1461 or
1244–1464) were expressed in Escherichia coli and purified on glutathione agarose beads (Sigma
Aldrich, St. Louis, MO) as previously described (Gardoni et al., 2001).
Pull-down assay
Three hundred micrograms of proteins were incubated with GST to a final volume of 1 ml with Tris
Buffered Saline solution for 45 min with shaking. Samples were centrifuged at 1000 rpm for 5 min
and the pellets were discarded. Supernatants were incubated for 2 hr with GST fusion proteins or
GST alone. Beads were washed four times with TBS and 0.1% Triton X-100. Bound proteins were
resolved by SDS-PAGE and subjected to immunoblot analysis.
Confocal studies
For co-localization and morphological studies, treated hippocampal neurons were fixed 7 min in 4%
paraformaldehyde plus 4% sucrose in PBS at room temperature; then extensively washed with PBS
supplemented with CaCl2 and MgCl2 (PBS-C.M), permeabilized with 0.2% Triton X100 in PSB-C.M
and blocked for 2 hr at room temperature with 5% BSA in PBS-C.M. Primary and secondary antibod-
ies were applied in 5% BSA in PBS-C.M. Cells were chosen randomly for quantification from different
coverslips. Fluorescence images were acquired by using Zeiss Confocal LSM510 Meta system with a
sequential acquisition setting at 1024x1024 pixels resolution; for each image two up to four 0.5mm
sections were acquired and a z projection was obtained (Malinverno et al., 2010). All images were
acquired standing the signals within the linear range in order to perform a reliable quantification
(avoiding the presence of any saturated pixel) and to compare appropriately all experimental condi-
tions. For analysis of dendritic spine morphology, primary hippocampal neurons were transfected
with GFP-containing constructs at DIV7. Cells were fixed and immunolabeled for GFP at DIV14. The
SP5 CLSM system (Leica-Microsystems, Mannheim, Germany) equipped with Diode (405 nm), Argon
(488 nm) and Diode Pumped Solid State (561 nm) lasers was used for time-lapse imaging of RNF10
fused to tdEOS. Images were taken with HCX APO L20x/1.00W objective (Leica, Germany). Along
the z-axis at list 10 optical sections with focus depth of 300–400 nm were taken in order to cover the
complete volume of imaged neurons. Quick change 18 mm Chamber with Field Stimulation (RC-
49MFS, Warner Instruments) was used for mounting coverslips with living overexpressing RFN10-
tdEOS neurons in Neurobasal medium (Gibco) on the microscope stage. Master-8/U 8-channel pro-
grammable pulse generator (Science Products) was used to generate timing and two channels were
synchronized to produce complex patterns of pulses (1 ms pulse duration) with inter pulse interval of
20 ms. To eliminate the distortion and thereby to achieve a rectangular pulse permitting accurate
measurement, the constant-current stimulus isolation unit (SIU-102, Warner Instruments) was used in
the output of a stimulus generator. The LTP was induced by applying current pulses 18s@50 Hz via
field stimulation electrode. Response of cultured hippocampal neurons on field synaptic stimulation
was verified by Ca2+-imaging with Fluo-4-AM (1 mM) (data not shown).
Electrophysiology
Miniature EPSCs were recorded on DIV14 hippocampal neurons at room temperature, at a holding
potential of -60 mV. The recording pipettes had resistance of around 5 MW when filled with the fol-
lowing medium (in mM): 140 CsCl, 0.5 CaCl2, 20 EGTA, 10 HEPES, 10 D-glucose, pH 7.2 and osmo-
larity of 300 mOsm. The high concentration of EGTA avoided slow Ca2+-dependent desensitization
of NMDARs. Neurons were perfused continuously with the following external medium (in mM): 140
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NaCl, 2 CaCl2, 3 KCl, 10 HEPES, 10 D-glucose, 0.01 glycine, 0.01 bicucullin, 0.0003 tetrodotoxin, pH
7.4 and osmolarity of 330 mOsm. Currents were recorded through an Axopatch 200B amplifier, fil-
tered at 1 kHz, digitized at 3 kHz and analyzed using the pClamp 10.0 software of Axon Instrument
(Molecular Devices, Sunnyvale, CA).
Quantification and statistical analysis
Acquisition and quantification of western blotting was performed by means of computer-assisted
imaging (ChemiDoc system and Image lab 4.0 software; Bio-Rad). Western blotting experiments
have been normalized on tubulin or H3 levels, depending if they have been performed from total
cell lysate (homogenate) or P1 nuclear fraction, respectively. Data obtained by pull-down assays
were normalized on the amount of GST fusion protein. The data from all quantifications were ana-
lyzed using Graphpad Prism software and levels and values were expressed as mean ± standard
error of the mean (SEM). Co-localization analysis was performed using Zeiss AIM4.2 software. Statis-
tical evaluations were performed by Student t test or Pearson correlations or, as appropriate, by
one-way ANOVA followed by Bonferroni’s or Tukey’s as a post-hoc test. When appropriate, experi-
ments have been performed in blind conditions.
Antibodies
The following antibodies were used: monoclonal antibody (mAb) anti-a-calcium/calmodulin-depen-
dent kinase II (aCaMKII), polyclonal antibody (pAb) anti-GluN2A, pAb anti-CREB, mAb anti-Myc,
pAb anti-GluA1 and pAb anti-p-CREB (Ser-133) were purchased from Millipore (Billenca, MA,USA);
mAb anti-Meox2 and pAb anti-Synaptotagmin were purchased from Abcam (Cambridge, MA, USA);
mAb anti-GluR2, mAb anti-GFP, mAb anti-GST and anti-PSD-95 were purchased from NeuroMab
(Davis, CA); mAb anti-a-Tubulin and mAb anti-Flag were purchased from Sigma-Aldrich (St. Louis,
MO); mAb anti-p21 and mAb anti-Rch1 (importin a1, KPNA2 gene product) were purchased from
BD Biosciences (Franklin Lakes, NJ); pAb anti-histone H3 was purchased from Proteintech
(Chicago, IL); pAb anti-RNF10 were purchased from ProteinTech and Santacruz; mAb anti-GluN2B
and p-GluA1(845) were purchased from Invitrogen (Carlsbad, CA); pAb anti-BDNF was purchased
from Genetex (Irvine, CA); mAb anti-Map2 was purchased from Immunological Sciences (Roma,
Italy); mAb anti-JL8 was purchased from Clontech (Mountain View, CA); pAb anti-ArhGap4 was pur-
chased from Novus Biologicals (Cambridge, UK); mAb anti-GFAP, pAb anti-Ophn1 and pAb anti-
ArhGef6 were purchased from Cell Signaling (Danvers, MA). Peroxidase-conjugated secondary anti-
mouse Ab was purchased from Pierce (Rockford, IL) while peroxidase-conjugated secondary anti-
rabbit Ab was purchased from Bio-Rad (Hercules, CA). AlexaFluor secondary Abs were purchased
from Invitrogen (Carlsbad, CA).
The specificity of the RNF10 antibody (ProteinTech) in recognizing RNF10 in western blotting and
immunocytochemistry was carefully verified by RNF10 overexpression and silencing in primary hip-
pocampal neurons (data not shown). The specificity of the importin a1 antibody (BD Biosciences) in
recognizing KPNA2 gene product in western blotting was carefully verified by KPNA1-6 overexpres-
sion in HEK293T cells (data not shown).
shRNA
The RNAi Consortium (TRC) shRNA target gene set in pLKO.1 lentiviral vector for rat RNF10 (acces-
sion number NM_001011904.1) along with scrambled vector were purchased from Open Biosystems
(Thermo Scientific, Milano, Italy). The set contained three vectors (the TRC IDs: TRCN0000041128,
mature antisense TTCAGGTTGATCTTCTTAGGG; TRCN0000041131, mature antisense TTTCTG
TGAATTGGAGCGACG; and TRCN0000041132, mature antisense ATACCCAGCAATCTCTACCAC),
all of them were validated by real-time PCR on rat hippocampal primary cultures. Vector
TRCN0000041128 showed the highest level of RNF10 downregulation (>90%, data not shown) and
was used in all further experiments (designated as shRNF10). To knock down rat GluN2A gene
expression, a set of 4 short hairpin RNA (shRNA) expression vectors in pGFP-V-RS was purchased
from Origene (Rockville, MD). The sequences were as follows: A-gacagcactcctatgataacattctggac; B-
tctaccagcaggactggtcacagaacaac; C-tgcgagccagatgacaaccacctcagcat; D-agtagaggtggctgtcagcact-
gaatcca. A scrambled control from Origene (Rockville, MD) was also used as a negative control.
Sequence called B showed the best knockdown and was therefore used for further experiments.
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For the testing and validation of sh-resistant form of RNF10, rat primary hippocampal cultures
were transfected with GFP (Ctrl), rat-shRNF10, RFP-humRNF10, and rat-shRNF10 + TRP-humRNF10.
Total RNA was extracted with Tryzol 48 hr after transfection, retrotranscribed (Improm II, Promega)
and analyzed by quantitative PCR using primers that specifically amplify rat RNF10 or human RNF10.
Transfection with rat-shRNF10 resulted in three fold decrease of endogenous RNF10 mRNA,
whereas transfection with human RFP tagged RNF10 resulted in 45-fold increase in mRNA for human
RNF10, the level which was not affected by rat-shRNF10 co-transfection. Interestingly, the overex-
pression of human RNF10 in rat hippocampal cells abolished effect of shRNF10 on levels of endoge-
nous RNF10 mRNA. The specificity of rat-shRNF10-mediated knock down was further tested using
human neuroblastoma line SY-S5Y5. No effect on both endogenous and everexpressed RNF10 was
observed after transfection with rat-shRNF10.
Viral constructs
Cloning of pLV-RNF10-EGFP. The cloning of this construct was accomplished in two steps. First,
EGFP was amplified from the pRRLSIN.cPPT.hCMV-EGFP.WPRE (pLV-EGFP) plasmid to create in
frame sequence with XbaI-SalI sites at 5’ of EGFP and XhoI sites at 3’ of EGFP using
primers: forward 5’-aagcttTCTAGAgaattcGTCGACATGGTGAGCAAGGGCGAGGA; reverse 5’-
aagcttCTCGAGTTACTTGTACAGCTCGTCCAT. Amplificate was digested with XbaI and XhoI
enzymes and ligated in XbaI-SalI digested pLV vector creating the intermediate pLV-(XS)EGFP bear-
ing XbaI-SalI cassette at 5’ of EGFP. After the sequence was confirmed by sequencing, human
RNF10 was excised from pCMV-Tag4-RNF10 plasmid by XbaI and SalI and ligated in XbaI/SalI
digested pLV-(XS)EGFP yielding pLV-RNF10-EGFP plasmid.
Production of viral particles
For production of lentiviral particles 2 mln of HEK293T producing cells were plated on 100 mm plates
(Costar, Milan, Italy) in complete medium (DMEM, Cat. D5671; 2 mM Glutamine; 100 units/ml penicil-
lin and 100 mg/ml streptomycin (Sigma); 10% Foetal Bovine Serum (FBS, Immunological Sciences,
Milano, Italy). For overexpression of RNF10, the day after plating the cells were transfected with 3mg
pL-shRNF10 or pGIPZ-scr and with 2.5 mg psPAX2 and 0.75 mg pMD2.G retroviral packaging con-
structs using Lipofectamine 2000 (Life Technologies, Milan, Italy) in 7 ml of complete medium. For
RNF10 silencing, the cells were transfected with 3 mg pLV-RNF10-EGFP, and with 2 mg pMDLg/pRRE,
0.75 mg pRSV-REV, 11 mg pMD2.G lentiviral packaging constructs. 48 hr after transfection culture
medium was collected, filtered through 0.45 mm PVDF filter and precipitated with polyethylene glycol
(PEG; 5x PEG solution contained: 200 g PEG, Sigma Cat. 89510, 12 g NaCl in 2 mM Tris pH 7.5) over-
night. Precipitates were then collected by centrifugation at 1500 xg for 30 min at 4˚C, resuspended in
cold HEPES balanced salt solution (HBSS, Sigma), aliquoted and snap frozen. Aliquots were kept at -
80˚C. Each viral batch was tittered by serial dilution infections of rat hippocampal primary cells by
means of real-time PCR (for RNF10 silencing) using primers for rat RNF10 (to evaluate efficacy of
downregulation): forward 5’-GAACAAGAGACAGGGCAGGT, reverse 5’-GACAGAGGGGTCAGCA-
GAAA. For experiments, a viral titer was used yielding > 80% of RNF10 downregulation. Virus for over-
expression was tittered by FACS, and a titer yielding > 80% EGFP positive cells was used.
Yeast two hybrid (Y2H) screening
Y2H was conducted according to the manufacture procedure guidelines using the Mate & PlateÔ
Library - Mouse Brain (Normalized) (cat # 630488, TakaraBio/Clontech Europe, France). Briefly, the
GluN2A(839–1461) C-tail (bait) was cloned in the pGBKT7 plasmid and transformed in the AH109
haploid yeast strain (MATa). This was mated overnight with the Mouse Brain normalized library
(prays) cloned in pGADT7 transformed in Y187 haploid yeast strain (MATa). Yeast were plated after
24 on selective plate, allowing only the growth of diploid where a protein interaction between the
bait and pray protein occurred (absence of Leucine, Adenine, Tryptophan and Histidine). Then the
diploid where tested by a colorimetric assay (a-gal) to avoid the presence of false positive. Plasmids
(21 positive clones) were extracted from the yeast and sequenced. Five genes were identified follow-
ing sequencing, one of those being RNF10.
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